Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropicamide/Phenylephrine for Pupil Dilation
NCT03751098Phase 3Completed
- Sponsor
- Hyperion DeFi
- Start
- Dec 2018
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Mydriasis, sponsored by Hyperion DeFi. Started Dec 2018; status: completed.
02
Conditions
Mydriasis
Beyond the preview
Go deeper on NCT03751098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751098.